Rockefeller Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
6CM
Rockefeller Capital Management's ANAB Position: Q3 2026 in Review
Rockefeller Capital Management held its AnaptysBio (ANAB) position steady in Q3 2026 at 153 shares worth $7.69K. The position accounts for ﹤0.01% of the portfolio, ranked #4263.
Rockefeller Capital Management first reported a position in ANAB in Q3 2018 and has held it in 9 quarters since. The position peaked at $203K in Q3 2018. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Rockefeller Capital Management held 153 shares of AnaptysBio worth $7.69K as of Q3 2026.
- Rockefeller Capital Management left its AnaptysBio share count unchanged in Q3 2026.
- AnaptysBio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4263 holding.
- Rockefeller Capital Management first reported a position in AnaptysBio in Q3 2018 and has held it in 9 quarters since.
- Rockefeller Capital Management's AnaptysBio position peaked at $203K in Q3 2018.
- 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.